( May 28, 2026, 12:14 PM EDT) -- NEW ORLEANS — The Louisiana federal judge overseeing the multidistrict litigation for cases alleging that a chemotherapy drug caused eye injuries limited testimony that a regulatory expert retained by the drug manufacturer can offer, finding that the neurologist is qualified but that some of her proposed testimony is impermissible under Federal Rule of Evidence 702, Fed. R. Evid. 702....